Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,493 papers from all fields of science
Search
Sign In
Create Free Account
Remoxipride
Known as:
(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide
, Remoxipridum
, Remoxipride [Chemical/Ingredient]
Expand
An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Broader (2)
Antipsychotic Agents
Dopamine Antagonists
Narrower (6)
FLA 908
FLA-731
NCQ 344
NCQ 436
Expand
In Blood
Remoxipride Hydrochloride
agonists
analogs & derivatives
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS.
E. Choong
,
S. Rudaz
,
Astrid Kottelat
,
D. Guillarme
,
J. Veuthey
,
C. Eap
Journal of Pharmaceutical and Biomedical Analysis
2009
Corpus ID: 25278388
Highly Cited
2009
Highly Cited
2009
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
H. Hall
,
M. Sällemark
,
E. Jerning
Acta Pharmacologica et Toxicologica
2009
Corpus ID: 1475474
A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic…
Expand
Highly Cited
2005
Highly Cited
2005
Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the rat
L. Slot
,
M. Kleven
,
A. Newman-Tancredi
Neuropharmacology
2005
Corpus ID: 39678734
2000
2000
New dopamine receptor, D2(Longer), with unique TG splice site, in human brain.
P. Seeman
,
D. Nam
,
C. Ulpian
,
I. S. Liu
,
T. Tallerico
Brain Research. Molecular Brain Research
2000
Corpus ID: 24255062
Highly Cited
1998
Highly Cited
1998
P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication
K. Coburn
,
S. Shillcutt
,
+4 authors
N. Moore
Biological Psychiatry
1998
Corpus ID: 45534622
Highly Cited
1996
Highly Cited
1996
Role of the parafascicular thalamic nucleus and N-methyl-d-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum
Silvana Consolo
,
P. Baronio
,
G. Guidi
,
G. Chiara
Neuroscience
1996
Corpus ID: 26935709
Highly Cited
1995
Highly Cited
1995
Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.
J. Arnt
European Journal of Pharmacology
1995
Corpus ID: 4528614
Highly Cited
1990
Highly Cited
1990
Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme
T. Lewander
,
S.‐E. Westerbergh
,
D. Morrison
Acta Psychiatrica Scandinavica Supplementum
1990
Corpus ID: 25294682
Abstract Nine double‐blind studies comparing remoxipride to haloperidol in the treatment of acute schizophrenia formed the basis…
Expand
Highly Cited
1990
Highly Cited
1990
Separation of anionic and cationic compounds of biomedical interest by high-performance liquid chromatography on porous graphitic carbon.
G. Gu
,
C. Lim
Journal of Chromatography A
1990
Corpus ID: 31612221
Highly Cited
1986
Highly Cited
1986
Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
C. Köhler
,
H. Hall
,
L. Gawell
European Journal of Pharmacology
1986
Corpus ID: 32480006
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE